Anemia patients with nonvalvular atrial fibrillation have a higher risk of dying, a study finds. Antithrombotic therapy with oral anticoagulants (OACs) was associated with reduced risk of ischemic events without ... In a meta-analysis, published in Catheterization and Cardiovascular Interventions, researchers concluded outcomes with ... According to a study in Jama Network Open, only about half of patients with atrial fibrillation with increased stroke ... In a study in the Journal of the American Geriatrics Society, researchers sought to characterize any associations ... Oral anticoagulation (OAC) therapy is used for stroke prevention in patients with atrial fibrillation (AFib), but does ... Assessing the Performance of Bleeding Scores in High-Risk VTE Patients
... Currently, scores for bleeding risk assessment in patients with venous thromboembolism (VTE) undergoing oral ... Investigators developed a novel model for bleeding prediction in patients with venous thromboembolism (VTE). The results ... An anticoagulant prophylactic dosing strategy for venous thromboembolism (VTE) could yield potential benefit in patients ... Stiff Arteries May Play an Important Role in HFpEF Mechanism & Prognosis
... A Scandinavian study suggested that the use of direct oral anticoagulants in patients with venous thromboembolism (VTE) ... Expert adjudication of electronic medical records (EMRs) revealed that oral anticoagulants are not as underused in ... Patients with diabetes taking insulin who also have nonvalvular atrial fibrillation (AFib) have an increased mortality ... A new study evaluated the risk of fracture among nonvalvular atrial fibrillation (AF) patients taking warfarin versus ... New research from the American Heart Association Scientific Sessions 2019 in Philadelphia suggest that different future ... New Orleans—There is an association between renal function and outcomes of patients receiving anticoagulation ... Oral anticoagulation alone (OAC) could not be shown as noninferior to oral anticoagulation plus an antiplatelet agent ... Warfarin and non-vitamin K oral anticoagulants both showed clinical benefit in very elderly atrial fibrillation (AFib) ...